PharmacoEconomics & Outcomes News 365 - 1 Jun 2002 New DM programmes for US company Following the launch of a new cardiovascular disease management (DM) programme and the acquisition of Quality Oncology, a provider of cancer DM programmes, Matria Healthcare Inc., will manage the five most costly diseases in the US, reports Disease Management News. The new programme, to be marketed to current employers and health plans, will manage patients with coronary artery disease, congestive heart failure or hypertensive disorders. When Quality Oncology’s DM care is included, Matria will manage diabetes mellitus, cancer, cardiovascular disease, respiratory disorders and obstetrical conditions. These diseases and conditions ‘cost the U.S. more than $500 billion each year in direct and indirect medical expenditures and lost productivity’, says Matria’s chairman, president and chief executive officer Parker Petit. Matria will be in a leading position to offer the most extensive range of major DM products and services in the US, he says. Matria to acquire quality oncology, launch cardiac DM program. Disease Management News 7: 1 & 6, 10 May 2002

800901079

1173-5503/10/0365-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

PharmacoEconomics & Outcomes News 1 Jun 2002 No. 365

1